Canadian small-cap stocks can offer growth that is harder to find in mature large-cap businesses, but a small market value does not make a stock cheap or safe. This 2026 shortlist compares five Canadian-listed businesses with different growth drivers, balance sheets and execution risks. I use roughly C$300 million to C$2 billion in equity market value as the starting range and check eligibility on a dated basis; prices can move a company across that boundary. That market-cap screen differs from the share-price-based under-C$5 screen in our Canadian penny-stock guide; the two categories are not interchangeable.
Market-cap snapshots cited below are from September 2026 and are approximate, while operating figures refer to each company’s latest reported second quarter of 2026 unless stated otherwise. They are not live prices or forecasts. The ranking is a qualitative watchlist for investors who can tolerate small-cap volatility, rather than a promise that any one stock will outperform.
Ready to start investing? Click the Qtrade banner below to learn more and open a Qtrade Direct Investing account.
How These Five Canadian Small-Cap Stocks Were Selected
I screened for Canadian-listed companies within the stated market-cap range, a credible way to expand revenue or earnings, and enough public reporting to test the growth thesis. I then weighed operating momentum, balance-sheet flexibility, competitive position, valuation risk and the chance of a setback. The #1-to-#5 order reflects that judgment; it is not a formula, and a lower-ranked stock could fit a different investor better. A company can leave this list if it grows beyond the small-cap definition or its thesis changes.
| Rank / company | Approx. Sept. 2026 market cap | Growth driver | Principal risk |
|---|---|---|---|
| #1 Firan Technology Group (FTG) | C$629m | Aerospace electronics and order backlog | Program timing and valuation |
| #2 Andean Precious Metals (APM) | C$909m | Bolivian and U.S. precious-metals operations | Commodity prices and jurisdiction |
| #3 Propel Holdings (PRL) | C$984m | Consumer lending platform growth | Credit losses and regulation |
| #4 VitalHub (VHI) | C$480m | Health-software recurring revenue and acquisitions | Integration and organic growth |
| #5 Docebo (DCBO) | C$806m | Enterprise learning software | Customer concentration and cash conversion |
#1 — Firan Technology Group (TSX: FTG)
Firan designs and manufactures electronic products for aerospace and defence customers. Its second-quarter 2026 release reported about C$52.7 million in revenue, with Aerospace revenue rising 21% year over year and management describing strong bookings and backlog. That demand offers a plausible runway, but orders do not arrive as smooth quarterly revenue. Production execution, customer programs and a share price that may already anticipate growth are the main checks on the thesis.
At roughly C$629 million of market value on September 25, Firan remained inside this article’s small-cap range. I rank it first for its visible industry demand and established manufacturing capability, while recognizing that defence spending alone does not guarantee margins or returns.
#2 — Andean Precious Metals (TSX: APM)
Andean combines its Bolivian precious-metals operations with Golden Queen in California. Its second-quarter 2026 company release reported US$67.6 million of revenue, down from US$73.7 million a year earlier, and described sales timing that shifted some metal inventory into a later period. That is a useful reminder that operating output, shipments and recognized revenue can move differently. Metal prices, mine performance and the political and operating risks of Bolivia matter alongside U.S. diversification.
The September 2026 market-cap snapshot was about C$909 million, within the stated range. Andean is a more cyclical candidate than the software names here; I would test cash generation across a weaker metals-price scenario rather than treat a favourable commodity tape as permanent.
#3 — Propel Holdings (TSX: PRL)
Propel provides technology-enabled consumer lending and financial services. Its second-quarter 2026 release reported US$179.6 million in revenue, up 26% year over year, but also a provision for loan losses equal to about 50% of revenue. Rapid loan growth is useful only if credit performance and funding costs remain controlled. Regulation, borrower stress and the sensitivity of reported earnings to credit assumptions make this a higher-risk financial holding.
At about C$984 million in the September 25 snapshot, Propel met the market-cap screen. I put it in the middle of the list because the growth and profitability opportunity is substantial, but comparing revenue growth without credit quality would give a misleading picture.
#4 — VitalHub (TSX: VHI)
VitalHub sells healthcare software and has grown through both recurring contracts and acquisitions. Its second-quarter 2026 release reported C$31.7 million in revenue, up 33% year over year, and annual recurring revenue above C$100 million. The company reported C$136.5 million of cash and short-term investments at June 30 and acquired Buddy Healthcare in July. Recurring revenue can make the business more resilient, but integration, implementation timelines and the pace of organic growth deserve close attention.
VitalHub was about C$480 million in the September 25 market-cap snapshot and therefore fits the C$300 million–C$2 billion definition. Savaria, another Canadian growth business, was approximately C$2.14 billion by the same date and therefore sat above this list’s ceiling. Market-cap eligibility is a screen, not a judgment about the quality of that business.
#5 — Docebo (TSX: DCBO)
Docebo sells enterprise learning software and has a recurring-revenue model, but its investment case must be tested against customer concentration and cash conversion. Second-quarter 2026 revenue was US$68.65 million, up 13% year over year, while free cash flow was US$3.1 million, below US$11.4 million a year earlier. The company also reported US$45.7 million in cash and US$88 million of borrowings at quarter-end. Those figures make balance-sheet and execution risks more relevant than a simple software-growth label.
The September market-cap snapshot was approximately C$806 million. I place Docebo fifth because the addressable market is attractive but growth, profitability and free cash flow do not always advance at the same pace. Investors should check its latest customer mix and guidance rather than extrapolate a single quarter.
How to Use This Small-Cap Shortlist
These are five different businesses, not interchangeable ways to buy “growth.” Aerospace contract cycles, precious-metal prices, consumer credit, healthcare software integration and enterprise technology budgets can produce very different outcomes. Position size and diversification matter because thinly traded shares may move sharply even when a long-term thesis has not changed.
Final Thoughts
Firan, Andean, Propel, VitalHub and Docebo form a current Canadian small-cap shortlist with identifiable growth drivers and equally identifiable risks. The market-cap screen and second-quarter 2026 operating data make the selections testable, while the ranking remains a judgment about quality and risk rather than a guaranteed return forecast. Recheck size, financial results and valuation before acting; a stock can stop qualifying as a small cap without becoming a poor business.
Company Sources and Data Dates
Operating information: FTG Q2 2026; Andean 2026 releases; Propel Q2 2026; VitalHub Q2 2026; Docebo Q2 2026. Approximate market caps are September 2026 snapshots and will change with share prices.
Ready to start investing? Click the Qtrade banner below to learn more and open a Qtrade Direct Investing account.
